Pirtobrutinib Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as LOXO ONCOL. It is marketed under 1 brand name, including JAYPIRCA. Available in 2 different strengths, such as 50MG, 100MG, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"111332","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"cae2c802573e42dd913d","publication_number":"US10918622B2","cleaned_patent_number":"10918622","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-12-16","publication_date":"2021-02-16","legal_status":"Granted"}	US10918622B2	16 Feb, 2021	Granted	16 Dec, 2036
{"application_id":"111334","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"cae2c802573e42dd913d","publication_number":"US10464905B2","cleaned_patent_number":"10464905","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-12-16","publication_date":"2019-11-05","legal_status":"Granted"}	US10464905B2	05 Nov, 2019	Granted	16 Dec, 2036
{"application_id":"111333","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"cae2c802573e42dd913d","publication_number":"US10695323B2","cleaned_patent_number":"10695323","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-12-16","publication_date":"2020-06-30","legal_status":"Granted"}	US10695323B2 Molecular Formulation	30 Jun, 2020	Granted	16 Dec, 2036
{"application_id":"111335","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"cae2c802573e42dd913d","publication_number":"US10342780B2","cleaned_patent_number":"10342780","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-12-16","publication_date":"2019-07-09","legal_status":"Granted"}	US10342780B2 Molecular Formulation	09 Jul, 2019	Granted	16 Dec, 2036
{"application_id":"164476","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"","publication_number":"US12220401B2","cleaned_patent_number":"12220401","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-12-16","publication_date":"2025-02-11","legal_status":"Granted"}	US12220401B2 Molecular Formulation	11 Feb, 2025	Granted	16 Dec, 2036
{"application_id":"121672","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"d3d2cd601db94146b38e","publication_number":"US20240238253A1","cleaned_patent_number":"12268666","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-07-29","publication_date":"2024-07-18","legal_status":"Pending"}	US12268666B2 Formulation	18 Jul, 2024	Pending	29 Jul, 2039
{"application_id":"110873","ingredient":"PIRTOBRUTINIB","trade_name":"JAYPIRCA","family_id":"d3d2cd601db94146b38e","publication_number":"US20210330643A1","cleaned_patent_number":"12109193","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-09-14","publication_date":"2021-10-28","legal_status":"Pending"}	US12109193B2 Formulation	28 Oct, 2021	Pending	14 Sep, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Pirtobrutinib

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.